Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BFLY NASDAQ:LMAT NASDAQ:NVCR NASDAQ:SSII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$1.41-17.5%$2.09$0.90▼$4.98$422.86M2.453.33 million shs10.64 million shsLMATLeMaitre Vascular$81.04-0.2%$82.52$71.42▼$109.58$1.84B0.82101,135 shs126,468 shsNVCRNovoCure$11.32-2.2%$16.61$10.91▼$34.13$1.29B0.611.70 million shs2.06 million shsSSIISS Innovations International$6.20-8.7%$5.88$0.32▼$22.42$1.31BN/A144,497 shs49,771 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network-17.30%-28.24%-28.43%-39.22%+25.89%LMATLeMaitre Vascular-0.25%-1.69%-3.35%+2.97%-6.73%NVCRNovoCure-2.16%-5.98%-36.69%-37.63%-50.29%SSIISS Innovations International-8.69%-13.65%+19.92%+619,999,900.00%+619,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBFLYButterfly Network2.6215 of 5 stars3.41.00.00.03.82.50.6LMATLeMaitre Vascular2.9562 of 5 stars2.23.03.30.02.12.51.3NVCRNovoCure4.3904 of 5 stars3.35.00.04.52.43.30.0SSIISS Innovations InternationalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBFLYButterfly Network 2.75Moderate Buy$3.50148.23% UpsideLMATLeMaitre Vascular 2.33Hold$97.8320.72% UpsideNVCRNovoCure 2.57Moderate Buy$28.79154.29% UpsideSSIISS Innovations International 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BFLY, LMAT, NVCR, and SSII Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/1/2025BFLYButterfly NetworkOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform7/25/2025NVCRNovoCureWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Equal Weight$40.00 ➝ $14.507/22/2025LMATLeMaitre VascularBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform7/8/2025NVCRNovoCureLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$30.007/1/2025BFLYButterfly NetworkCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$3.006/27/2025NVCRNovoCurePiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$34.005/5/2025BFLYButterfly NetworkLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$5.00 ➝ $4.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBFLYButterfly Network$82.06M4.25N/AN/A$0.79 per share1.78LMATLeMaitre Vascular$226.26M8.09$2.38 per share34.01$15.00 per share5.40NVCRNovoCure$605.22M2.09N/AN/A$3.13 per share3.62SSIISS Innovations International$20.65M58.13N/AN/A$0.08 per share77.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBFLYButterfly Network-$72.49M-$0.29N/AN/AN/A-75.56%-29.97%-21.13%N/ALMATLeMaitre Vascular$44.04M$1.9840.9337.352.1419.96%13.53%9.78%8/5/2025 (Estimated)NVCRNovoCure-$168.63M-$1.56N/AN/AN/A-27.13%-47.74%-13.79%N/ASSIISS Innovations International-$19.15MN/A0.00∞N/A-67.73%-70.64%-32.95%N/ALatest BFLY, LMAT, NVCR, and SSII EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025LMATLeMaitre Vascular$0.57N/AN/AN/A$62.48 millionN/A7/24/2025Q2 2025NVCRNovoCure-$0.39-$0.36+$0.03-$0.36$153.87 million$158.80 million5/2/2025Q1 2025BFLYButterfly Network-$0.09-$0.06+$0.03-$0.06$21.16 million$21.23 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBFLYButterfly NetworkN/AN/AN/AN/AN/ALMATLeMaitre Vascular$0.800.99%N/A40.40%14 YearsNVCRNovoCureN/AN/AN/AN/AN/ASSIISS Innovations InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBFLYButterfly NetworkN/A6.064.43LMATLeMaitre Vascular0.4816.4913.83NVCRNovoCure0.281.451.39SSIISS Innovations InternationalN/A3.182.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBFLYButterfly Network37.85%LMATLeMaitre Vascular84.64%NVCRNovoCure84.61%SSIISS Innovations InternationalN/AInsider OwnershipCompanyInsider OwnershipBFLYButterfly Network25.18%LMATLeMaitre Vascular9.50%NVCRNovoCure5.52%SSIISS Innovations InternationalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBFLYButterfly Network460247.29 million185.02 millionOptionableLMATLeMaitre Vascular49022.59 million20.45 millionOptionableNVCRNovoCure1,488111.80 million105.63 millionOptionableSSIISS Innovations International4193.60 millionN/AN/ABFLY, LMAT, NVCR, and SSII HeadlinesRecent News About These CompaniesSS Innovations International (NASDAQ:SSII) Shares Gap Up - Still a Buy?July 25, 2025 | marketbeat.comSS Innovations Announces Completion of World’s First Intercontinental Robotic Cardiac TelesurgeryJuly 23, 2025 | finance.yahoo.comSS Innovations International (NASDAQ:SSII) Shares Gap Down - Here's WhyJuly 22, 2025 | marketbeat.comSS Innovations Announces Completion of World's First Intercontinental Robotic Cardiac TelesurgeryJuly 22, 2025 | prismmediawire.comPSS Innovations Announces Completion of World's First Intercontinental Robotic Cardiac TelesurgeryJuly 22, 2025 | globenewswire.comSS Innovations International (NASDAQ:SSII) Sees Large Volume Increase - Here's WhyJuly 18, 2025 | marketbeat.comSS Innovations International (NASDAQ:SSII) Shares Down 7.7% - Should You Sell?July 18, 2025 | marketbeat.comSSII - SS Innovations International Inc Ownership | MorningstarJuly 17, 2025 | morningstar.comMSS Innovations International (NASDAQ:SSII) Shares Up 7.1% - Still a Buy?July 16, 2025 | marketbeat.comSS Innovations International (NASDAQ:SSII) Shares Gap Up - Here's What HappenedJuly 15, 2025 | marketbeat.comSS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic SystemJuly 15, 2025 | prismmediawire.comPSS Innovations International (NASDAQ:SSII) Shares Gap Down - Time to Sell?July 11, 2025 | marketbeat.comSS Innovations International (NASDAQ:SSII) Shares Up 13.7% - Here's What HappenedJuly 10, 2025 | marketbeat.comSS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic SystemJuly 10, 2025 | prismmediawire.comPSS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic SystemJuly 10, 2025 | globenewswire.comSS Innovations International (NASDAQ:SSII) Trading Down 8.7% - Should You Sell?July 8, 2025 | marketbeat.comSS Innovations International (NASDAQ:SSII) Trading Up 6.4% - Here's WhyJuly 3, 2025 | marketbeat.comSS Innovations International (NASDAQ:SSII) Trading Down 5.5% - Here's What HappenedJuly 2, 2025 | marketbeat.comSS Innovations: A Speculative Bet On Robotic SurgeriesJune 19, 2025 | seekingalpha.comSS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic SystemJune 16, 2025 | prismmediawire.comPSS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic SystemJune 16, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBFLY, LMAT, NVCR, and SSII Company DescriptionsButterfly Network NYSE:BFLY$1.41 -0.30 (-17.54%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$1.46 +0.05 (+3.19%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.LeMaitre Vascular NASDAQ:LMAT$81.04 -0.20 (-0.25%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$81.10 +0.06 (+0.07%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.NovoCure NASDAQ:NVCR$11.32 -0.25 (-2.16%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$11.55 +0.23 (+2.02%) As of 08/1/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.SS Innovations International NASDAQ:SSII$6.20 -0.59 (-8.69%) As of 08/1/2025 04:00 PM EasternAVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
